Passage BIO, Inc. 8-K — AI Bull & Bear Analysis

The 8-K filing confirms the successful completion of Passage Bio's 2026 Annual Meeting, resulting in the election of Class III directors and the ratification of KPMG as auditors. While the proposals passed, the tension between the high percentage of 'for' votes and the significant number of withheld shares creates a mixed signal for investors. The outcome ensures operational continuity but highlights a need for management to bridge the gap with a skeptical minority of shareholders.